Novartis Pharma SA
207.8 FTENovartis Pharma reported revenue of €378.6m for the 2025 financial year (annual accounts filed with the NBB on 05 Jun 2026), with 207.8 full-time equivalents.
By total assets for 2025, Novartis Pharma ranks among the 20 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year. Largest companies in the sector →
The score of Novartis Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +17 % Equity -56 % Total assets +3 % Headcount (avg FTE) -26 %
Accounts of the company itself (not consolidated).
The full file covers 12 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Novartis Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €378.6m | ||||
| Net result | €11.5m | ||||
| Equity | €32.1m | ||||
| Cash | 67,203 € | ||||
| EBITDA | €12.1m | ||||
| Total assets | €168.8m |
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Jun 2026
- Year ended 31 Dec 2024filed on 06 Jun 2025
- Year ended 31 Dec 2023filed on 06 Jun 2024
- Year ended 31 Dec 2022filed on 07 Jun 2023
- Year ended 31 Dec 2021filed on 03 Jun 2022
Novartis Pharma's financial analysis
- Solvency19.0%sector median: 46.0%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Novartis Pharma
Novartis Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0459.093.476
- VAT number
- BE0459093476
- Peppol
- Registered · 0208:0459093476 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 25 Oct 1996
- Registered office
- 1831 Machelen (Brab.)
- Size
- Medium · 207.8 FTE
- Latest accounts
- 2025 · filed on 05 Jun 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Novartis Pharma (SA) has been based in Machelen (Brab.) since 1996, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €378.6m, a net profit of €11.5m and equity of €32.1m. With 207.8 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 19.0%, below the median of its sector (46.0%).
Guide: Checking a Belgian supplier invoice: numbers and IBAN →
Companies similar to Novartis Pharma
Companies in the same business, of comparable size and area, outside its group.
- Sanofi Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €218.9m
- EG Wholesale of pharmaceutical and medical goods Brussels · balance sheet €113.6m
- PHOENIX Pharma Belgium Manufacture of pharmaceutical preparations Woluwe-Saint-Lambert · balance sheet €235.4m
- Vertex Pharmaceuticals (Belgium) Wholesale of pharmaceutical and medical goods Brussels · balance sheet €84.4m
- Eli Lilly Benelux Wholesale of pharmaceutical and medical goods Brussels · balance sheet €79.7m
- Menarini Benelux Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €48.6m
- O&M Halyard Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €45.9m
- Biogen Belgium Wholesale of pharmaceutical and medical goods Machelen (Brab.) · balance sheet €25.5m
Frequently asked questions about Novartis Pharma
What is the revenue of Novartis Pharma?
According to the 2025 annual accounts filed with the NBB, the revenue of Novartis Pharma amounts to 378,550,712 €.
What is the VAT number of Novartis Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0459093476 for Novartis Pharma, if the company is VAT-registered. Its company number (CBE) is 0459.093.476.
Where is the registered office of Novartis Pharma?
According to the CBE register, the registered office of Novartis Pharma is in 1831 Machelen (Brab.).
What is the equity of Novartis Pharma?
At the close of the 2025 financial year, the equity of Novartis Pharma amounts to 32,114,015 €, a solvency of 19.0% of total assets.
How many people work at Novartis Pharma?
207.8 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Novartis Pharma?
The register lists 3 active mandates at Novartis Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
How large is Novartis Pharma within its sector?
By total assets for 2025, Novartis Pharma ranks among the 20 largest of the 968 companies in its sector (NACE 4646) in Belgium that filed accounts for that financial year.
The full file of Novartis Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →